D printing is a good option for bioreactor production. The flexibility of the approach outweighs concerns about higher costs.
Cultivated meat substitutes, medicines and mass-produced proteins for food hold vast market potential, and environmental benefits, while addressing ethical concerns presented by livestock farming. The ...
On December 1, Pfizer became the first big pharma to commit to take to market a late-stage biologic drug produced in plant cells. It acquired rights to taligurase alfa, a form of the enzyme ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results